These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32992645)

  • 1. Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy-Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells.
    Ratschker T; Egenberger L; Alev M; Zschiesche L; Band J; Schreiber E; Frey B; Derer A; Alexiou C; Janko C
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32992645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation.
    Nguyen K; Nuß B; Mühlberger M; Unterweger H; Friedrich RP; Alexiou C; Janko C
    Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32796757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of drug-loaded nanoparticles to tumor sites increases cell death and release of danger signals.
    Alev M; Egenberger L; Mühleisen L; Weigel B; Frey B; Friedrich RP; Pöttler M; Alexiou C; Janko C
    J Control Release; 2018 Sep; 285():67-80. PubMed ID: 30008372
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.
    Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C
    Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.
    Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S
    Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
    Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
    Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Setup for Determination of Nanoparticle-Mediated Magnetic Cell and Drug Accumulation in Tumor Spheroids under Flow Conditions.
    Behr J; Carnell LR; Stein R; Pfister F; Friedrich B; Huber C; Lyer S; Band J; Schreiber E; Alexiou C; Janko C
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
    Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
    J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy.
    Janko C; Ratschker T; Nguyen K; Zschiesche L; Tietze R; Lyer S; Alexiou C
    Front Oncol; 2019; 9():59. PubMed ID: 30815389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Parr MA; Marchenko YY; Eliseev I; Yudenko A; Dobrodumov AV; Zlobina O; Zhakhov A; Ischenko AM; Pitkin E; Multhoff G
    J Control Release; 2015 Dec; 220(Pt A):329-340. PubMed ID: 26522072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
    Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
    Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
    Alexiou C; Jurgons R; Schmid RJ; Bergemann C; Henke J; Erhardt W; Huenges E; Parak F
    J Drug Target; 2003 Apr; 11(3):139-49. PubMed ID: 13129824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunogenicity, danger signals, and DAMPs: what, when, and how?
    Garg AD; Dudek AM; Agostinis P
    Biofactors; 2013; 39(4):355-67. PubMed ID: 23900966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential.
    Frey B; Stache C; Rubner Y; Werthmöller N; Schulz K; Sieber R; Semrau S; Rödel F; Fietkau R; Gaipl US
    J Immunotoxicol; 2012; 9(3):301-13. PubMed ID: 22800185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of Mitoxantrone-loaded Superparamagnetic Iron Oxide Nanoparticles in a HT-29 Tumour Spheroid Model.
    Hornung A; Poettler M; Friedrich RP; Weigel B; Duerr S; Zaloga J; Cicha I; Alexiou C; Janko C
    Anticancer Res; 2016 Jun; 36(6):3093-101. PubMed ID: 27272833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Branched Polyethylenimine-Superparamagnetic Iron Oxide Nanoparticles (bPEI-SPIONs) Improve the Immunogenicity of Tumor Antigens and Enhance Th1 Polarization of Dendritic Cells.
    Hoang MD; Lee HJ; Lee HJ; Jung SH; Choi NR; Vo MC; Nguyen-Pham TN; Kim HJ; Park IK; Lee JJ
    J Immunol Res; 2015; 2015():706379. PubMed ID: 26221615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy.
    Zhao X; Yang K; Zhao R; Ji T; Wang X; Yang X; Zhang Y; Cheng K; Liu S; Hao J; Ren H; Leong KW; Nie G
    Biomaterials; 2016 Sep; 102():187-97. PubMed ID: 27343466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver--magnetic nanoparticles in cancer treatment.
    Krukemeyer MG; Krenn V; Jakobs M; Wagner W
    J Surg Res; 2012 Jun; 175(1):35-43. PubMed ID: 21470623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.